Pay to Marwadi

Company Profile

CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE1650.00-7.85 (-0.47 % )
PREV CLOSE (Rs.) 1657.85
OPEN PRICE (Rs.) 1657.85
BID PRICE (QTY) 1647.50 (1 )
OFFER PRICE (QTY) 1651.90 (4 )
VOLUME 583
TODAY'S LOW / HIGH (Rs.)1649.65 1657.85
52 WK LOW / HIGH (Rs.)900 1711.95
NSE1650.00 -8.9 (-0.54 % )
PREV CLOSE(Rs.) 1658.90
OPEN PRICE (Rs.) 1655.00
BID PRICE (QTY) 1650.00 (23 )
OFFER PRICE (QTY) 1650.50 (10 )
VOLUME 1132
TODAY'S LOW / HIGH(Rs.) 1650.00 1655.95
52 WK LOW / HIGH (Rs.)900.05 1725

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 9.6195
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 27.91
ROCE (%) 26.48
Incorporation Year : 1984

Management Info :

Sudhir Vaid - Chairman Sudhir Vaid - Managing Director

Registered Office :

Address : 1482-86 ,Trasad Road,Dholka,
Ahmedabad,
Gujarat-382225

Phone : 079-68138700

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
15Apr04-15-2024$ Reply To Clarification Sought On Volume Movement Reply To Clarification Soug
We hereby submit that the company has disclosed all the material information/announcement or events from time to time to the exchange which may have bearing on the operation/performance of the company which includes all the necessary disclosures in accordance with regulation 30 of SEBI (LODR) regulation, 2015 and under insider trading regulation, have always been disclosed by the company within stipulated time and the same is available in public domain. There is no pending information or announcement which have a bearing on increase in volume of shares of the company. Therefore, the increase in volume of shares is purely due to market condition and absolutely market driven and the company is in no way connected with any such increase in volume. We hope the above clarifies and request you to kindly take the same on records.
We hereby submit that the company has disclosed all the materia..
06Mar03-06-2024$Concord Biotech informs about updates Concord Biotech informs abou

In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has informed that Brazilian Health Regulatory Agency (ANVISA) has Issued Certificate of Good Manufacturing Practices of its Unit I (API facility) of the Company, located at Trasad Road, Dholka - 382225 in Ahmedabad, Gujarat.

The above information is a part of company’s filings submitted to BSE.

In compliance with Regulation 30 of SEBI (Listing Obligations a..
23Feb02-23-2024$Concord Biotech gets GMP for unit II of Gujarat facility Concord Biotech gets GMP for

Ministry of Health Pharmacy and Poisons Board, Republic of Kenya has completed inspection at Concord Biotech’s Unit II (formulation facility), located at Valthera-Dholka in Ahmedabad, Gujarat. The said inspection has been completed successfully, without any adverse remarks and the company has received the certificate of Good manufacturing practices (GMP) as on February 22, 2024. 

The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series and other internationally acceptable guidelines. 

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Ministry of Health Pharmacy and Poisons Board, Republic of Keny..
23Feb02-23-2024$Concord Biotech gains on getting GMP for unit II of Gujarat facility Concord Biotech gains on get

Concord Biotech is currently trading at Rs. 1463.65, up by 23.40 points or 1.62% from its previous closing of Rs. 1440.25 on the BSE.

The scrip opened at Rs. 1441.05 and has touched a high and low of Rs. 1477.15 and Rs. 1441.05 respectively. So far 3957 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 1608.20 on 10-Jan-2024 and a 52 week low of Rs. 900.00 on 18-Aug-2023.

Last one week high and low of the scrip stood at Rs. 1477.15 and Rs. 1370.15 respectively. The current market cap of the company is Rs. 15312.15 crore.

The promoters holding in the company stood at 44.08%, while Institutions and Non-Institutions held 15.40% and 40.52% respectively.

Ministry of Health Pharmacy and Poisons Board, Republic of Kenya has completed inspection at Concord Biotech’s Unit II (formulation facility), located at Valthera-Dholka in Ahmedabad, Gujarat. The said inspection has been completed successfully, without any adverse remarks and the company has received the certificate of Good manufacturing practices (GMP) as on February 22, 2024. 

The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series and other internationally acceptable guidelines. 

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Concord Biotech is currently trading at Rs. 1463.65, up by 23.4..
09Feb02-09-2024$Concord Biotech informs about investor presentation Concord Biotech informs abou
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has informed that investor’s presentation on Financial Results for the Third quarter and Nine months ended December 31, 2023 is enclosed.

The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listi..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL
Net Profit745.54
Gross Profit 1000.85
Operating Profit 1141.17
Net Sales
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Ajanta Pharma (BSE)
 2440.00 (9.27%)
M.Cap ( in Cr)
28118.22
Torrent Pharma (BSE)
 2713.20 (1.47%)
M.Cap ( in Cr)
90493.54
Pfizer (BSE)
 4302.85 (0.68%)
M.Cap ( in Cr)
19550.75
Solara Active Pharma (BSE)
 560.80 (5.24%)
M.Cap ( in Cr)
1918.24
Natco Pharma (BSE)
 1038.10 (2.68%)
M.Cap ( in Cr)
18108.01
Shareholding Pattern More
MUTUAL FUNDS/UTI 5.15 %
PROMOTERS 44.08 %
NON-INSTITUTION 41.03 %
FI/BANKS/INSURANCE 2.88 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes